[1] Vassileva, S., Drenovska, K. and Manuelyan, K. (2014) Autoimmune Blistering Dermatoses as Systemic Diseases. Clinics in Dermatology, 32, 364-375.
https://doi.org/10.1016/j.clindermatol.2013.11.003
[2] Brick, K.E., Weaver, C.H., Lohse, C.M., Pittelkow, M.R., Lehman, J.S., Camilleri, M.J., et al. (2014) Incidence of Bullous Pemphigoid and Mortality of Patients with Bullous Pemphigoid in Olmsted County, Minnesota, 1960 through 2009. Journal of the American Academy of Dermatology, 71, 92-99.
https://doi.org/10.1016/j.jaad.2014.02.030
[3] Said, S. and Golitz, L. (2011) Vesiculobullous Eruptions of the Oral Cavity. Otolaryngologic Clinics of North America, 44, 133-160.
https://doi.org/10.1016/j.otc.2010.09.005
[4] Mays, J.W., Sarmadi, M. and Moutsopoulos, N.M. (2012) Oral Manifestations of Systemic Autoimmune and Inflammatory Diseases: Diagnosis and Clinical Management. Journal of Evidence-Based Dental Practice, 12, 265-282.
https://doi.org/10.1016/S1532-3382(12)70051-9
[5] Munhoz Ede, A., Cardoso, C.L., Barreto, J.A., Soareas, C.T. and Damante, J.H. (2011) Severe Manifestation of Oral Pemphigus. American Journal of Otolaryngology, 32, 338-342.
https://doi.org/10.1016/j.amjoto.2010.03.005
[6] Martin, M.D. (2009) Gingival Nikolsky’s Sign Is Useful for Clinical Diagnosis. Journal of Evidence-Based Dental Practice, 9, 217-218.
https://doi.org/10.1016/j.jebdp.2009.06.004
[7] Ramos-e-Silva, M., Ferreira, A. and Jacques, C. (2011) Oral Involvement in Autoimmune Bullous Diseases. Clinics in Dermatology, 29, 443-454.
https://doi.org/10.1016/j.clindermatol.2011.01.015
[8] Sebaratnam, D.F. and Murrell, D.F. (2011) Objective Scoring Systems for Disease Activity in Autoimmune Bullous Disease. Dermatologic Clinics, 29, 515-520.
https://doi.org/10.1016/j.det.2011.03.015
[9] Lobene, R.R., Weatherford, T., Ross, N.M., Lamm, R.A. and Menaker, L. (1986) A Modified Gingival Index for Use in Clinical Trials. Clinical Preventive Dentistry, 8, 3-6.
[10] Ruocco, V., Ruocco, E., Lo Schiavo, A., Brunetti, G., Guerrera, L.P. and Wolf, R. (2013) Pemphigus: Etiology, Pathogenesis, and Inducing or Triggering Factors: Facts and Controversies. Clinics in Dermatology, 31, 374-381.
https://doi.org/10.1016/j.clindermatol.2013.01.004
[11] Sticherling, M. and Erfurt-Berge, C. (2012) Autoimmune Blistering Diseases of the Skin. Autoimmunity Reviews, 11, 226-230.
https://doi.org/10.1016/j.autrev.2011.05.017
[12] Markle, J.G. and Fish, E.N. (2014) SeXX Matters in Immunity. Trends in Immunology, 35, 97-104.
https://doi.org/10.1016/j.it.2013.10.006
[13] Zhao, C.Y. and Murrell, D.F. (2015) Autoimmune Blistering Diseases in Females: A Review. International Journal of Women’s Dermatology, 1, 4-12.
https://doi.org/10.1016/j.ijwd.2015.01.002
[14] Gupta, V.K., Kelbel, T.E., Nguyen, D., Melonakos, K.C., Murrell, D.F., Xie, Y., et al. (2011) A Globally Available Internet-Based Patient Survey of Pemphigus Vulgaris: Epidemiology and Disease Characteristics. Dermatologic Clinics, 29, 393-404.
https://doi.org/10.1016/j.det.2011.03.016
[15] Carvalho Junior, J.R. (2012) Interrelationship between Oral and Systemic Diseases: The Role of the Dental Surgeon in Diagnosis and Treatment. Oral Science, 4, 2-5.
https://portalrevistas.ucb.br/index.php/oralsciences/article/view/8400
[16] Gonçalves, P.G.P., Serpa, M.S., Pereira, L.L., Silveira, E.J.D.S., Glavão, H.C., Freitas, R.A., et al. (2015) Periodontal Manifestations Associated with Autoimmune Diseases: A Literature Review. Revista Brasileira de Medicina, 72, 423-429.
http://www.moreirajr.com.br/revistas.asp?fase=r003&id_materia=6213
[17] Navarro Triviño, F.J., Ruíz Villaverde, R., Díaz Martínez, M.A. and Naranjo Sintes, R. (2017) Dapsone: Update of a Classic Drug in Current Dermatological Uses. Piel, 32, 173-177.
[18] Fernandes, N.C. and Menezes, M. (2013) Pulse Therapy in Pemphigus: Report of 11 Cases. Anais Brasileiros de Dermatologia, 88, 672-675.
https://doi.org/10.1590/abd1806-4841.20131840
[19] Strowd, L.C., Taylor, S.L., Jorizzo, J.L. and Namazi, M.R. (2011) Therapeutic Ladder for Pemphigus Vulgaris: Emphasis on Achieving Complete Remission. Journal of the American Academy of Dermatology, 64, 490-494.
https://doi.org/10.1016/j.jaad.2010.02.052
[20] Ferreira, V.Y.N., Lyra, T.C., Pereira, L.L., Nascimento, M.A.B., Souza, L.B. and Bonan, P.R.F. (2016) Therapeutic Effectiveness of Systemic Steroid on Oral Pemphigus Vulgaris Treatment. Arquivos de Ciências da Saúde, 23, 10-13.
https://doi.org/10.17696/2318-3691.23.3.2016.215
[21] Carvalho, C.H., Santos, B.R., Vieira Cde, C., Lima, E.d., Santos, P.P. and Freitas Rde, A. (2011) An Epidemiological Study of Immune-Mediated Skin Diseases Affecting the Oral Cavity. Anais Brasileiros de Dermatologia, 86, 905-909.
https://doi.org/10.1590/S0365-05962011000500007
[22] Jaafari-Ashkavandi, Z., Mardani, M., Pardis, S. and Amanpour, S. (2011) Oral Mucocutaneous Diseases: Clinicopathologic Analysis and Malignant Transformation. Journal of Craniofacial Surgery, 22, 949-951.
https://doi.org/10.1097/SCS.0b013e31820fe1f0
[23] Moreira, A.A.M.S.S., Rodrigues, O.C.S.F. and Mota, A.J.V. (2013) Autoimmune Blistering Diseases. Revista da Sociedade Portuguesa de Dermatologia e Venereologia, 71, 325-335.
[24] Cho, Y.-T., Kao, J.-T., Chen, H.-J., Wang, L.-F. and Chu, C.-Y. (2014) Paraneoplastic Pemphigus: A Retrospective Case Series in a Referral Center in Northern Taiwan. Dermatologica Sinica, 32, 1-6.
https://doi.org/10.1016/j.dsi.2013.04.006
[25] Baum, S., Sakka, N., Artsi, O., Trau, H. and Barzilai, A. (2014) Diagnosis and Classification of Autoimmune Blistering Diseases. Autoimmunity Reviews, 13, 482-489.
https://doi.org/10.1016/j.autrev.2014.01.047
[26] Mustafa, M.B., Porter, S.R., Smoller, B.R. and Sitaru, C. (2015) Oral Mucosal Manifestations of Autoimmune Skin Diseases. Autoimmunity Reviews, 14, 930-951.
https://doi.org/10.1016/j.autrev.2015.06.005
[27] Kaur, B. and Sheikh, S. (2013) Clinical Evaluation of Oral Lesions Associated with Dermatologic Diseases. Archives of Oral Research, 9, 15-22.
https://doi.org/10.7213/archivesoforalresearch.09.001.AO01
[28] Hennings, C. and Miller, J. (2013) Illicit Drugs: What Dermatologists Need to Know. Journal of the American Academy of Dermatology, 69, 135-142.
https://doi.org/10.1016/j.jaad.2012.12.968
[29] Brewer, J.D., Meves, A., Bostwick, J.M., Hamacher, K.L. and Pittelkow, M.R. (2008) Cocaine Abuse: Dermatologic Manifestations and Therapeutic Approaches. Journal of the American Academy of Dermatology, 59, 483-487.
https://doi.org/10.1016/j.jaad.2008.03.040
[30] Arduino, P.G., Farci, V., D’Aiuto, F., Carcieri, P., Carbone, M. and Tanteri, C. (2011) Periodontal Status in Oral Mucous Membrane Pemphigoid: Initial Results of a Case-Control Study. Oral Diseases, 17, 90-94.
https://doi.org/10.1111/j.1601-0825.2010.01709.x
[31] Kershenovich, R., Hodak, E. and Mimouni, D. (2014) Diagnosis and Classification of Pemphigus and Bullous Pemphigoid. Autoimmunity Reviews, 13, 477-481.
https://doi.org/10.1016/j.autrev.2014.01.011
[32] Ohki, M., Kikuchi, S., Ohata, A., Baba, Y., Ishikawa, J. and Sugimoto, H. (2016) Features of Oral, Pharyngeal, and Laryngeal Lesions in Bullous Pemphigoid. Ear, Nose & Throat Journal, 95, E1-E5.
[33] Iranzo, P., Herrero-González, J.E., Mascaró-Galy, J.M., Suárez-Fernández, R. and España, A. (2014) Epidermolysis Bullosa Acquisita: A Retrospective Analysis of 12 Patients Evaluated in Four Tertiary Hospitals in Spain. British Journal of Dermatology, 171, 1022-1030.
https://doi.org/10.1111/bjd.13144
[34] Rebouças, D.S., Cerqueira, L.S., Costa, T.F., Ferreira, T.G., Naves, R.C. and Zerbinati, L.P.S. (2014) Pemphigus Vulgaris the Importance of Knowledge of the Surgeon Dentist for a Correct Diagnosis. Revista Bahiana de Odontologia, 5, 174-181.
[35] Thorat, M.S., Raju, A. and Pradeep, A.R. (2010) Pemphigus Vulgaris: Effects on Periodontal Health. Journal of Oral Science, 52, 449-454.
https://doi.org/10.2334/josnusd.52.449
[36] Sebaratnam, D.F., Frew, J.W., Davatchi, F., et al. (2012) Quality-of-Life Measurement in Blistering Diseases. Dermatologic Clinics, 30, 301-307.
https://doi.org/10.1016/j.det.2011.11.008
[37] Borgnakke, W.S. (2015) Does Treatment of Periodontal Disease Influence Systemic Disease? Dental Clinics of North America, 59, 885-917.
https://doi.org/10.1016/j.cden.2015.06.007
[38] Lo Schiavo, A., Ruocco, E., Brancaccio, G., Caccavale, S., Ruocco, V. and Wolf, R. (2013) Bullous Pemphigoid: Etiology, Pathogenesis, and Inducing Factors: Facts and Controversies. Clinics in Dermatology, 31, 391-399.
https://doi.org/10.1016/j.clindermatol.2013.01.006
[39] Tricamo, M.B., Rees, T.D., Hallmon, W.W., Wright, J.M., Cueva, M.A. and Plemons, J.M. (2006) Periodontal Status in Patients with Gingival Mucous Membrane Pemphigoid. Journal of Periodontology, 77, 398-405.
https://doi.org/10.1902/jop.2006.050113
[40] Gagari, E. and Damoulis, P.D. (2011) Desquamative Gingivitis as a Manifestation of Chronic Mucocutaneous Disease. Journal der Deutschen Dermatologischen Gesellschaft, 9, 184-187.
https://doi.org/10.1111/j.1610-0387.2010.07543.x